Back
Aptevo Therapeutics, Inc. 10K Form
Sell
36
APVO
Aptevo Therapeutics, Inc.
Last Price:
$1.40
Seasonality Move:
-19.09%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-14 | 10Q | APVO/Aptevo Therapeutics, Inc. Quarterly |
| 2023-08-10 | 10Q | APVO/Aptevo Therapeutics, Inc. Quarterly |
| 2023-05-11 | 10Q | APVO/Aptevo Therapeutics, Inc. Quarterly |
| 2022-11-10 | 10Q | APVO/Aptevo Therapeutics, Inc. Quarterly |
| 2022-08-11 | 10Q | APVO/Aptevo Therapeutics, Inc. Quarterly |
| 2022-05-12 | 10Q | APVO/Aptevo Therapeutics, Inc. Quarterly |
Receive APVO News And Ratings
See the #1 stock for the next 7 days that we like better than APVO
APVO Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-6.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.26 |
| Price / Book: | 0.26 |
Profitability
| EPS (TTM): | -185.06610 |
|---|---|
| Net Income (TTM): | $-28M |
| Gross Margin: | $-352K |
| Return on Equity: | -442.03% |
| Return on Assets: | -171.07% |
Aptevo Therapeutics, Inc. Earnings Forecast
Key Aptevo Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 12 years have been positive in 6 years.
Aptevo Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | APVO |
| CUSIP: | 03835L |
| Website: | aptevotherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0.23 |
|---|---|
| Current Ratio: | 4.03 |
| Quick Ratio: | 3.75 |
Price-to-Earnings
| Trailing P/E Ratio: | 0.12 |
|---|---|
| Forward P/E Ratio: | 0 |
APVO Technical Analysis vs Fundamental Analysis
Sell
36
Aptevo Therapeutics, Inc. (APVO)
is a Sell
Is Aptevo Therapeutics, Inc. a Buy or a Sell?
-
Aptevo Therapeutics, Inc. stock is rated a SellThe current Aptevo Therapeutics, Inc. [APVO] share price is $1.39. The Score for APVO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.